These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 20934363

  • 1. Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI.
    Auray-Blais C, Bhérer P, Gagnon R, Young SP, Zhang HH, An Y, Clarke JT, Millington DS.
    Mol Genet Metab; 2011 Jan; 102(1):49-56. PubMed ID: 20934363
    [Abstract] [Full Text] [Related]

  • 2. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
    Zhang H, Wood T, Young SP, Millington DS.
    Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
    [Abstract] [Full Text] [Related]

  • 3. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
    Khan SA, Mason RW, Giugliani R, Orii K, Fukao T, Suzuki Y, Yamaguchi S, Kobayashi H, Orii T, Tomatsu S.
    Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.
    Kubaski F, Suzuki Y, Orii K, Giugliani R, Church HJ, Mason RW, Dũng VC, Ngoc CT, Yamaguchi S, Kobayashi H, Girisha KM, Fukao T, Orii T, Tomatsu S.
    Mol Genet Metab; 2017 Mar; 120(3):247-254. PubMed ID: 28065440
    [Abstract] [Full Text] [Related]

  • 8. Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans.
    de Ru MH, van der Tol L, van Vlies N, Bigger BW, Hollak CE, Ijlst L, Kulik W, van Lenthe H, Saif MA, Wagemans T, van der Wal WM, Wanders RJ, Wijburg FA.
    J Inherit Metab Dis; 2013 Mar; 36(2):247-55. PubMed ID: 22991166
    [Abstract] [Full Text] [Related]

  • 9. A modified liquid chromatography/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses.
    Chuang CK, Lin HY, Wang TJ, Tsai CC, Liu HL, Lin SP.
    Orphanet J Rare Dis; 2014 Sep 02; 9():135. PubMed ID: 25178307
    [Abstract] [Full Text] [Related]

  • 10. Quantification of glycosaminoglycans in urine by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry.
    Zhang H, Young SP, Millington DS.
    Curr Protoc Hum Genet; 2013 Sep 02; Chapter 17():Unit 17.12. PubMed ID: 23315926
    [Abstract] [Full Text] [Related]

  • 11. Normalization of glycosaminoglycan-derived disaccharides detected by tandem mass spectrometry assay for the diagnosis of mucopolysaccharidosis.
    Lin HY, Lo YT, Wang TJ, Huang SF, Tu RY, Chen TL, Lin SP, Chuang CK.
    Sci Rep; 2019 Jul 24; 9(1):10755. PubMed ID: 31341247
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An improved method for glycosaminoglycan analysis by LC-MS/MS of urine samples collected on filter paper.
    Auray-Blais C, Lavoie P, Zhang H, Gagnon R, Clarke JT, Maranda B, Young SP, An Y, Millington DS.
    Clin Chim Acta; 2012 Apr 11; 413(7-8):771-8. PubMed ID: 22285314
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of dermatan sulfate and heparan sulfate concentrations in serum, cerebrospinal fluid and urine in patients with mucopolysaccharidosis type I receiving intravenous and intrathecal enzyme replacement therapy.
    Zhang H, Dickson PI, Stiles AR, Chen AH, Le SQ, McCaw P, Beasley J, Millington DS, Young SP.
    Clin Chim Acta; 2020 Sep 11; 508():179-184. PubMed ID: 32442432
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. LC-MS/MS method for simultaneous quantification of heparan sulfate and dermatan sulfate in urine by butanolysis derivatization.
    Forni G, Malvagia S, Funghini S, Scolamiero E, Mura M, Della Bona M, Villanelli F, Damiano R, la Marca G.
    Clin Chim Acta; 2019 Jan 11; 488():98-103. PubMed ID: 30395869
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS.
    Tanaka N, Kida S, Kinoshita M, Morimoto H, Shibasaki T, Tachibana K, Yamamoto R.
    Mol Genet Metab; 2018 Sep 11; 125(1-2):53-58. PubMed ID: 30064964
    [Abstract] [Full Text] [Related]

  • 19. Mucopolysaccharidoses type II: enzymatic activity and quantitative and qualitative studies of urinary glycosaminoglycans in five patients.
    Gallegos-Arreola MP, González-Noriega A, Zúñiga-González GM, Flores-Martínez SE, Morán Moguel MC, Figuera LE, Sánchez-Corona J.
    Arch Med Res; 1997 Sep 11; 28(1):91-4. PubMed ID: 9078594
    [Abstract] [Full Text] [Related]

  • 20. Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses.
    Shimada T, Kelly J, LaMarr WA, van Vlies N, Yasuda E, Mason RW, Mackenzie W, Kubaski F, Giugliani R, Chinen Y, Yamaguchi S, Suzuki Y, Orii KE, Fukao T, Orii T, Tomatsu S.
    Mol Genet Metab; 2014 Sep 11; 113(1-2):92-9. PubMed ID: 25092413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.